EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Impact of concomitant deep vein thrombosis on outcomes of acute pulmonary embolism: Insights from the PERT consortium registry

Ka U Lio, Wissam A Jaber, Sanjum Sethi, Steven Horbal, Belinda N Rivera-Lebron, Rachel P Rosovsky, Charles B Ross, Eric Secemsky, Parth Rali

Journal of Vascular Surgery: Venous and Lymphatic Disorders · 2026-07 · 14 (4) · 102499

DOI: 10.1016/j.jvsv.2026.102499 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2026-07. Verfasst von Ka U Lio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Emory University, Atlanta, GA. Electronic address: klio@emory.edu. Hauptthemen laut MEDLINE: Pulmonary Embolism, Venous Thrombosis. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Boston Scientific Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Studies have reported conflicting data regarding the prognostic significance of concomitant deep vein thrombosis (DVT) in acute pulmonary embolism (PE). Understanding the potential differences between PE with and without DVT is crucial for optimizing strategies. METHODS: Using data from The Pulmonary Embolism Response Teams Consortium Registry, this study examined the association between concomitant DVT and clinical outcomes in patients with predominantly acute intermediate- and high-risk PE. A secondary aim was to assess the impact of DVT on treatment selection, particularly the use of advanced therapies. RESULTS: Among 7346 patients with acute PE, 5076 (69%) had concomitant DVT. Patients with DVT were more frequently classified as intermediate-risk compared with patients without DVT, including intermediate-high (59.31% vs 51.9%; P < .001) and intermediate-low risk PE (19.4% vs 17.7%; P < .001). The presence of DVT was significantly associated with higher odds of receiving advanced therapies (odds ratio [OR], 2.49; 95% confidence interval [CI], 2.14-2.81), particularly catheter-directed therapy (OR, 2.44; 95% CI, 2.12-2.83), with the strongest association observed in the intermediate- to high-risk group (OR, 2.67; 95% CI, 2.25-3.18). Concomitant proximal DVT was not associated with increased in-hospital mortality (OR, 0.87; 95% CI, 0.69-1.09), 30-day mortality (OR, 0.96; 95% CI, 0.77-1.20), 1-year mortality (OR, 0.87; 95% CI, 0.73-1.03), or intensive care unit admission (OR, 1.05; 95% CI, 0.93-1.20), after adjustment for advanced therapy use. CONCLUSIONS: In this large contemporary cohort of predominantly intermediate- and high-risk PE, concomitant DVT was common and associated with more severe presentation and greater use of advanced therapies, but not with higher short- or long-term mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismVenous ThrombosisAgedFemaleHumansMaleMiddle AgedAcute DiseaseHospital MortalityRegistriesRisk AssessmentRisk FactorsThrombolytic TherapyTime FactorsTreatment Outcome

Stichwörter der Autor:innen

Catheter-directed thrombolysisDeep vein thrombosisPERTPulmonary embolism

Autor:innen und Institutionen

  • Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Emory University, Atlanta, GA. Electronic address: klio@emory.edu.
  • Division of Cardiology, Emory University, Atlanta, GA.
  • Division of Cardiovascular Disease, New York-Presbyterian/Columbia University Irving Medical Center, New York City, NY.
  • Frankel Cardiovascular Center, University of Michigan Health, Ann Arbor, MI.
  • Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
  • Division of Hematology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

Förderung

  • Boston Scientific Corporation

Zitieren

APA

Lio, K. U., Jaber, W. A., Sethi, S., Horbal, S., Rivera-Lebron, B. N., Rosovsky, R. P., Ross, C. B., Secemsky, E., & Rali, P. (2026). Impact of concomitant deep vein thrombosis on outcomes of acute pulmonary embolism: Insights from the PERT consortium registry. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 14(4), 102499. https://doi.org/10.1016/j.jvsv.2026.102499

Vancouver

Lio KU, Jaber WA, Sethi S, Horbal S, Rivera-Lebron BN, Rosovsky RP, et al. Impact of concomitant deep vein thrombosis on outcomes of acute pulmonary embolism: Insights from the PERT consortium registry. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2026;14(4):102499. doi:10.1016/j.jvsv.2026.102499

BibTeX
@article{Lio2026,
  author = {Lio, Ka U and Jaber, Wissam A and Sethi, Sanjum and Horbal, Steven and Rivera-Lebron, Belinda N and Rosovsky, Rachel P and Ross, Charles B and Secemsky, Eric and Rali, Parth},
  title = {Impact of concomitant deep vein thrombosis on outcomes of acute pulmonary embolism: Insights from the PERT consortium registry},
  journal = {Journal of Vascular Surgery: Venous and Lymphatic Disorders},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {102499},
  doi = {10.1016/j.jvsv.2026.102499}
}
Kostenlos starten →